Haloperidol Tablets, Mylan Pharmaceuticals Inc.

DRUG2 trials

Sponsors

Cycle Pharmaceuticals Ltd.

Conditions

Bioequivalence

Phase 1

Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fed Conditions

CompletedNCT04411953

Cycle Pharmaceuticals Ltd.Bioequivalence

Start: 2019-11-15End: 2019-12-19Updated: 2022-06-08

Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions

CompletedNCT04411940

Cycle Pharmaceuticals Ltd.Bioequivalence

Start: 2019-11-15End: 2019-12-18Updated: 2022-06-08